Agnès Boyer-Chammard

2.9k total citations · 1 hit paper
14 papers, 1.3k citations indexed

About

Agnès Boyer-Chammard is a scholar working on Oncology, Immunology and Hematology. According to data from OpenAlex, Agnès Boyer-Chammard has authored 14 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 7 papers in Immunology and 3 papers in Hematology. Recurrent topics in Agnès Boyer-Chammard's work include Cancer Immunotherapy and Biomarkers (5 papers), CAR-T cell therapy research (4 papers) and Immune Cell Function and Interaction (4 papers). Agnès Boyer-Chammard is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), CAR-T cell therapy research (4 papers) and Immune Cell Function and Interaction (4 papers). Agnès Boyer-Chammard collaborates with scholars based in France, United States and Italy. Agnès Boyer-Chammard's co-authors include Ricardo Pasqüini, Claude Chastang, Vanderson Rocha, Gérard Souillet, Eurípedes Ferreira, Éliane Gluckman, Juan Ortega, Franco Locatelli, William Arcese and J. P. Laporte and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Cancer.

In The Last Decade

Agnès Boyer-Chammard

14 papers receiving 1.3k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Outcome of Cord-Blood Transplantation from Related and Unrelated Donors

1997 953 citations Éliane Gluckman, Vanderson Rocha et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Agnès Boyer-Chammard France	9	944	442	363	344	163	14	1.3k
Mei Jie Zhang China	7	1.1k 1.1×	422 1.0×	378 1.0×	294 0.9×	139 0.9×	15	1.4k
Mary Laughlin United States	12	1.1k 1.1×	575 1.3×	390 1.1×	360 1.0×	153 0.9×	28	1.5k
Michael Cabbad United States	9	1.0k 1.1×	457 1.0×	405 1.1×	234 0.7×	208 1.3×	17	1.3k
Manuel N. Fernández Spain	12	1.2k 1.2×	649 1.5×	392 1.1×	237 0.7×	164 1.0×	17	1.4k
N. Ludy Dobrila United States	5	1.2k 1.3×	565 1.3×	458 1.3×	260 0.8×	204 1.3×	5	1.4k
Sławomira Kyrcz‐Krzemień Poland	21	906 1.0×	279 0.6×	345 1.0×	284 0.8×	150 0.9×	115	1.4k
Andrew Dagis United States	20	897 1.0×	207 0.5×	363 1.0×	329 1.0×	105 0.6×	38	1.4k
Janice F. Olson United States	7	770 0.8×	353 0.8×	282 0.8×	176 0.5×	117 0.7×	12	955
P. B. Mcglave United States	19	1.3k 1.3×	357 0.8×	472 1.3×	394 1.1×	112 0.7×	24	1.7k
Steven Neudorf United States	21	1.0k 1.1×	280 0.6×	265 0.7×	239 0.7×	85 0.5×	40	1.4k

Countries citing papers authored by Agnès Boyer-Chammard

Since Specialization

Citations

This map shows the geographic impact of Agnès Boyer-Chammard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Agnès Boyer-Chammard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Agnès Boyer-Chammard more than expected).

Fields of papers citing papers by Agnès Boyer-Chammard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Agnès Boyer-Chammard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Agnès Boyer-Chammard. The network helps show where Agnès Boyer-Chammard may publish in the future.

Co-authorship network of co-authors of Agnès Boyer-Chammard

This figure shows the co-authorship network connecting the top 25 collaborators of Agnès Boyer-Chammard. A scholar is included among the top collaborators of Agnès Boyer-Chammard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Agnès Boyer-Chammard. Agnès Boyer-Chammard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Kim, Y. H., M. Bagot, Pablo L. Ortiz‐Romero, et al.. (2023). LACUTAMAB IN PATIENTS WITH ADVANCED MYCOSIS FUNGOIDES (MF): EFFICACY RESULTS ACCORDING TO UPDATED LYMPH NODE (LN) CLASSIFICATION IN THE TELLOMAK STUDY. Hematological Oncology. 41(S2). 196–197. 2 indexed citations

Bagot, M., Hyun Soo Kim, Pier Luigi Zinzani, et al.. (2021). Lacutamab in patients (pts) with advanced mycosis fungoides (MF) according to KIR3DL2 expression: early results from the TELLOMAK phase 2 trial. European Journal of Cancer. 156. S20–S21. 1 indexed citations

Fayette, Jérôme, Jessica R. Bauman, Sébastien Salas, et al.. (2020). 81P Monalizumab in combination with cetuximab post platinum and anti-PD-(L)1 in patients with recurrent/metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): Updated results from a phase II trial. Annals of Oncology. 31. S1450–S1450. 3 indexed citations

Cohen, Roger B., Jessica R. Bauman, Sébastien Salas, et al.. (2020). Combination of monalizumab and cetuximab in recurrent or metastatic head and neck cancer patients previously treated with platinum-based chemotherapy and PD-(L)1 inhibitors.. Journal of Clinical Oncology. 38(15_suppl). 6516–6516. 32 indexed citations

Cohen, Romain, G. Lefebvre, Marshall R. Posner, et al.. (2019). Monalizumab in combination with cetuximab in patients (pts) with recurrent or metastatic (R/M) head and neck cancer (SCCHN) previously treated or not with PD-(L)1 inhibitors (IO): 1-year survival data. Annals of Oncology. 30. v460–v460. 16 indexed citations

Cohen, Roger B., Jérôme Fayette, Marshall R. Posner, et al.. (2018). Abstract CT158: Phase II study of monalizumab, a first-in-class NKG2A monoclonal antibody, in combination with cetuximab in previously treated recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): Preliminary assessment of safety and efficacy. Cancer Research. 78(13_Supplement). CT158–CT158. 10 indexed citations

Cohen, Roger B., Sébastien Salas, Caroline Even, et al.. (2017). Abstract 5666: Safety of the first-in-class anti-NKG2A monoclonal antibody monalizumab in combination with cetuximab: a phase Ib/II study in recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN). Cancer Research. 77(13_Supplement). 5666–5666. 2 indexed citations

Marino, Patricia, Gilles Houvenaeghel, Fabrice Narducci, et al.. (2015). Cost-Effectiveness of Conventional vs Robotic-Assisted Laparoscopy in Gynecologic Oncologic Indications. International Journal of Gynecological Cancer. 25(6). 1102–1108. 36 indexed citations

Blaise, Didier, Jean‐Marie Boher, Agnès Boyer-Chammard, et al.. (2014). Low non-relapse mortality and long-term preserved quality of life in older patients undergoing matched related donor allogeneic stem cell transplantation: a prospective multicenter phase II trial. Haematologica. 100(2). 269–274. 18 indexed citations

10.

Gonçalvès, Anthony, Étienne Brain, Carole Tarpin, et al.. (2012). Abstract OT2-3-05: AVASTEM: a phase II randomized trial evaluating anti-cancer stem cell activity of pre-operative bevacizumab and chemotherapy in breast cancer. Cancer Research. 72(24_Supplement). OT2–3. 3 indexed citations

11.

Blaise, Didier, Reza Tabrizi, Jean‐Marie Boher, et al.. (2012). Randomized study of 2 reduced‐intensity conditioning strategies for human leukocyte antigen‐matched, related allogeneic peripheral blood stem cell transplantation. Cancer. 119(3). 602–611. 53 indexed citations

12.

Boyer-Chammard, Agnès, Thomas H. Taylor, & Hoda Anton‐Culver. (1999). Survival Differences in Breast Cancer among Racial/Ethnic Groups: A Population-Based Study. Cancer Detection and Prevention. 23(6). 463–473. 98 indexed citations

13.

Gluckman, Éliane, Vanderson Rocha, Agnès Boyer-Chammard, et al.. (1998). Outcome of Cord-Blood Transplantation From Related and Unrelated Donors. Obstetrical & Gynecological Survey. 53(1). 19–20. 72 indexed citations

14.

Gluckman, Éliane, Vanderson Rocha, Agnès Boyer-Chammard, et al.. (1997). Outcome of Cord-Blood Transplantation from Related and Unrelated Donors. New England Journal of Medicine. 337(6). 373–381. 953 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact